amantadine
Commercial- Indications
- Parkinson's disease, Levodopa-induced dyskinesia
Company intelligence / Profile preview
Adamas Pharmaceuticals, Inc.
Emeryville, California, United Statespmc.ncbi.nlm.nih.gov ↗
- Ownership
- Public · ADMS
- Employees
- ~44
- Development stage
- Commercial
01
Overview
Adamas has FDA-approved products including GOCOVRI (amantadine extended release) for treatment of dyskinesia in Parkinson's disease patients and as an adjunctive treatment to levodopa/carbidopa in Parkinson's disease patients experiencing OFF episodes. The company also has OSMOLEX ER for treating Parkinson's disease. Their ADS-5102 showed significant improvement in walking speed for multiple sclerosis patients in Phase 2 trials.
- Therapeutic areas
- Neurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Financials
- Market cap
- $0
- Total revenue
- $25.9M
- Enterprise value
- $51M
Beyond the preview
Go deeper on Adamas Pharmaceuticals, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Adamas Pharmaceuticals, Inc..